NASDAQ:DOMH Dominari - DOMH Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Dominari Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $3.36 +0.11 (+3.38%) (As of 03/24/2023 12:00 AM ET) Add Compare Share Share Today's Range$3.28▼$3.3750-Day Range$2.98▼$4.4552-Week Range$2.88▼$10.20Volume27,633 shsAverage Volume30,608 shsMarket Capitalization$18.45 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsSocial Media About Dominari (NASDAQ:DOMH) StockDominari Holdings, Inc. is a biotechnology development company, which engages in the provision of diversified portfolio of small-molecule anticancer and antiviral therapeutics in development. Its oncology therapeutics includes treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. It also creates a broad-spectrum antiviral platform, in which the lead compounds have activity against multiple viruses including Influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2, the cause of COVID-19. The company was founded by Gilbert V. Levin and M. Karen Levin in 1967 and is headquartered in New York, NY.Read More Receive DOMH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Dominari and its competitors with MarketBeat's FREE daily newsletter. Email Address DOMH Stock News HeadlinesMarch 26, 2023 | americanbankingnews.comDominari (DOMH) Scheduled to Post Quarterly Earnings on MondaySee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive DOMH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Dominari and its competitors with MarketBeat's FREE daily newsletter. Email Address DOMH Company Calendar Today3/26/2023Next Earnings (Estimated)3/27/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Commercial physical research Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:DOMH CUSIPN/A CIK12239 WebN/A Phone(112) 745-1374Fax703-992-9348EmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)($3.8805) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-7,170,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-18.21% Return on Assets-16.94% Debt Debt-to-Equity RatioN/A Current Ratio29.54 Quick Ratio29.54 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$19.27 per share Price / Book0.17Miscellaneous Outstanding Shares5,490,000Free Float5,013,000Market Cap$18.45 million OptionableNot Optionable Beta0.96 Key ExecutivesAnthony C. HayesDirector, Chief Executive & Financial OfficerChristopher DevallChief Operating OfficerDarrell DotsonVice President-Drug Development & General CounselKey CompetitorsAIkido PharmaNASDAQ:AIKISunshine BiopharmaNASDAQ:SBFMiSpecimenNASDAQ:ISPCbioAffinity TechnologiesNASDAQ:BIAFScience 37NASDAQ:SNCEView All Competitors DOMH Stock - Frequently Asked Questions How have DOMH shares performed in 2023? Dominari's stock was trading at $3.28 at the beginning of the year. Since then, DOMH stock has increased by 2.4% and is now trading at $3.36. View the best growth stocks for 2023 here. When is Dominari's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, March 27th 2023. View our DOMH earnings forecast. What is Dominari's stock symbol? Dominari trades on the NASDAQ under the ticker symbol "DOMH." How do I buy shares of Dominari? Shares of DOMH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Dominari's stock price today? One share of DOMH stock can currently be purchased for approximately $3.36. How much money does Dominari make? Dominari (NASDAQ:DOMH) has a market capitalization of $18.45 million. The company earns $-7,170,000.00 in net income (profit) each year or ($3.8805) on an earnings per share basis. How can I contact Dominari? Dominari's mailing address is One Rockefeller Plaza, 11Th Floor, New York, New York 10020. The company can be reached via phone at (112) 745-1374, via email at investorrelations@aikidopharma.com, or via fax at 703-992-9348. This page (NASDAQ:DOMH) was last updated on 3/26/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.